323 related articles for article (PubMed ID: 33299886)
1. Dexmedetomidine Protects against Myocardial Ischemia/Reperfusion Injury by Ameliorating Oxidative Stress and Cell Apoptosis through the Trx1-Dependent Akt Pathway.
Wu ZL; Davis JRJ; Zhu Y
Biomed Res Int; 2020; 2020():8979270. PubMed ID: 33299886
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
Chang JH; Jin MM; Liu JT
Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987
[TBL] [Abstract][Full Text] [Related]
3. Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway.
Zhang J; Jiang H; Liu DH; Wang GN
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6736-6743. PubMed ID: 31378917
[TBL] [Abstract][Full Text] [Related]
4. Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury.
Cheng XY; Gu XY; Gao Q; Zong QF; Li XH; Zhang Y
Mol Med Rep; 2016 Jul; 14(1):797-803. PubMed ID: 27221008
[TBL] [Abstract][Full Text] [Related]
5. Involvement of GPR30 in protection effect of Dexmedetomidine against myocardial ischemia/reperfusion injury in rat via AKT pathway.
Shao Z; Shen Q; Kong M; Ni H; Hou X
Acta Biochim Pol; 2021 Feb; 68(1):119-126. PubMed ID: 33629579
[TBL] [Abstract][Full Text] [Related]
6. Effects of Dexmedetomidine Postconditioning on Myocardial Ischemia/Reperfusion Injury in Diabetic Rats: Role of the PI3K/Akt-Dependent Signaling Pathway.
Cheng X; Hu J; Wang Y; Ye H; Li X; Gao Q; Li Z
J Diabetes Res; 2018; 2018():3071959. PubMed ID: 30402501
[TBL] [Abstract][Full Text] [Related]
7. Troxerutin attenuates oxygen‑glucose deprivation and reoxygenation‑induced oxidative stress and inflammation by enhancing the PI3K/AKT/HIF‑1α signaling pathway in H9C2 cardiomyocytes.
Yu ZP; Yu HQ; Li J; Li C; Hua X; Sheng XS
Mol Med Rep; 2020 Aug; 22(2):1351-1361. PubMed ID: 32626962
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway.
Zhao Y; Kong GY; Pei WM; Zhou B; Zhang QQ; Pan BB
Eur Cytokine Netw; 2019 Sep; 30(3):88-97. PubMed ID: 31957703
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine Attenuates Hypoxia/Reoxygenation Injury of H9C2 Myocardial Cells by Upregulating miR-146a Expression via the MAPK Signal Pathway.
Chu Y; Teng J; Feng P; Liu H; Wang F; Wang H
Pharmacology; 2022; 107(1-2):14-27. PubMed ID: 34718238
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine postconditioning attenuates myocardial ischemia/reperfusion injury by activating the Nrf2/Sirt3/SOD2 signaling pathway in the rats.
Hu B; Tian T; Li XT; Hao PP; Liu WC; Chen YG; Jiang TY; Chen PS; Cheng Y; Xue FS
Redox Rep; 2023 Dec; 28(1):2158526. PubMed ID: 36738240
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine reversed hypoxia/reoxygenation injury-induced oxidative stress and endoplasmic reticulum stress-dependent apoptosis of cardiomyocytes via SIRT1/CHOP signaling pathway.
Zhang Y; Zhao Q; Li X; Ji F
Mol Cell Biochem; 2021 Jul; 476(7):2803-2812. PubMed ID: 33725228
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine Ameliorates Cardiac Ischemia/Reperfusion Injury by Enhancing Autophagy Through Activation of the AMPK/SIRT3 Pathway.
He H; Liu P; Li P
Drug Des Devel Ther; 2023; 17():3205-3218. PubMed ID: 37908314
[TBL] [Abstract][Full Text] [Related]
13. Tournefolic acid B, derived from Clinopodium chinense (Benth.) Kuntze, protects against myocardial ischemia/reperfusion injury by inhibiting endoplasmic reticulum stress-regulated apoptosis via PI3K/AKT pathways.
Yu Y; Xing N; Xu X; Zhu Y; Wang S; Sun G; Sun X
Phytomedicine; 2019 Jan; 52():178-186. PubMed ID: 30599897
[TBL] [Abstract][Full Text] [Related]
14. REDD1 knockdown protects H9c2 cells against myocardial ischemia/reperfusion injury through Akt/mTORC1/Nrf2 pathway-ameliorated oxidative stress: An in vitro study.
Li P; Lin N; Guo M; Huang H; Yu T; Zhang L
Biochem Biophys Res Commun; 2019 Oct; 519(1):179-185. PubMed ID: 31493869
[TBL] [Abstract][Full Text] [Related]
15. Trimetazidine protects against myocardial ischemia/reperfusion injury by inhibiting excessive autophagy.
Wu S; Chang G; Gao L; Jiang D; Wang L; Li G; Luo X; Qin S; Guo X; Zhang D
J Mol Med (Berl); 2018 Aug; 96(8):791-806. PubMed ID: 29955901
[TBL] [Abstract][Full Text] [Related]
16. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine attenuates ischemia and reperfusion-induced cardiomyocyte injury through p53 and forkhead box O3a (FOXO3a)/p53-upregulated modulator of apoptosis (PUMA) signaling signaling.
Yang FY; Zhang L; Zheng Y; Dong H
Bioengineered; 2022 Jan; 13(1):1377-1387. PubMed ID: 34974801
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine pretreatment attenuates myocardial ischemia reperfusion induced acute kidney injury and endoplasmic reticulum stress in human and rat.
Tang C; Hu Y; Gao J; Jiang J; Shi S; Wang J; Geng Q; Liang X; Chai X
Life Sci; 2020 Sep; 257():118004. PubMed ID: 32621918
[TBL] [Abstract][Full Text] [Related]
19. Polydatin Protects Diabetic Heart against Ischemia-Reperfusion Injury via Notch1/Hes1-Mediated Activation of Pten/Akt Signaling.
Yu L; Li Z; Dong X; Xue X; Liu Y; Xu S; Zhang J; Han J; Yang Y; Wang H
Oxid Med Cell Longev; 2018; 2018():2750695. PubMed ID: 29636838
[TBL] [Abstract][Full Text] [Related]
20. 25-Hydroxyl-protopanaxatriol protects against H
Wang Z; Su G; Zhang Z; Dong H; Wang Y; Zhao H; Zhao Y; Sun Q
Biomed Pharmacother; 2018 Mar; 99():33-42. PubMed ID: 29324310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
